• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Quinolone-resistance mechanisms and in vitro susceptibility patterns among European isolates of Streptococcus mitis, Streptococcus sanguis, and Streptococcus pneumoniae.

作者信息

Schmitz F J, Fisher A, Boos M, Mayer S, Milatovic D, Fluit A C

机构信息

Institute for Medical Microbiology and Virology, Heinrich-Heine University Düsseldorf, Germany.

出版信息

Eur J Clin Microbiol Infect Dis. 2001 Mar;20(3):219-22. doi: 10.1007/pl00011257.

DOI:10.1007/pl00011257
PMID:11347679
Abstract
摘要

相似文献

1
Quinolone-resistance mechanisms and in vitro susceptibility patterns among European isolates of Streptococcus mitis, Streptococcus sanguis, and Streptococcus pneumoniae.
Eur J Clin Microbiol Infect Dis. 2001 Mar;20(3):219-22. doi: 10.1007/pl00011257.
2
In vitro exchange of fluoroquinolone resistance determinants between Streptococcus pneumoniae and viridans streptococci and genomic organization of the parE-parC region in S. mitis.肺炎链球菌与草绿色链球菌之间氟喹诺酮耐药决定子的体外交换及缓症链球菌中parE-parC区域的基因组组织
J Infect Dis. 1999 Aug;180(2):555-8. doi: 10.1086/314888.
3
In vitro activity of gemifloxacin (SB-265805) compared to eleven other antimicrobial agents against streptococcal isolates, excluding Streptococcus pneumoniae.与其他十一种抗菌药物相比，吉米沙星（SB - 265805）对链球菌分离株（不包括肺炎链球菌）的体外活性。
Eur J Clin Microbiol Infect Dis. 2001 Apr;20(4):271-5. doi: 10.1007/pl00011264.
4
Comparative in vitro activity of moxifloxacin against Gram-positive clinical isolates.莫西沙星对革兰氏阳性临床分离株的体外活性比较
J Antimicrob Chemother. 2000 Jan;45(1):31-9. doi: 10.1093/jac/45.1.31.
5
Comparison of gyrA and parC mutations and resistance levels among fluoroquinolone-resistant isolates and laboratory-derived mutants of oral streptococci.耐氟喹诺酮口腔链球菌分离株与实验室衍生突变株中gyrA和parC基因突变及耐药水平的比较。
J Antimicrob Chemother. 2000 Jun;45(6):771-5. doi: 10.1093/jac/45.6.771.
6
Evaluation of susceptibility testing to detect fluoroquinolone resistance mechanisms in Streptococcus pneumoniae.评估肺炎链球菌中检测氟喹诺酮耐药机制的药敏试验。
Antimicrob Agents Chemother. 2001 Jun;45(6):1911-4. doi: 10.1128/AAC.45.6.1911-1914.2001.
7
Fluoroquinolone resistance among recent clinical isolates of Streptococcus pneumoniae.近期肺炎链球菌临床分离株中的氟喹诺酮耐药性。
J Antimicrob Chemother. 1999 Mar;43(3):428-9. doi: 10.1093/jac/43.3.428.
8
In vitro development of resistance to newer fluoroquinolones in Streptococcus pneumoniae isolates with reduced susceptibility to ciprofloxacin.对环丙沙星敏感性降低的肺炎链球菌分离株对新型氟喹诺酮类药物的体外耐药性发展
Eur J Clin Microbiol Infect Dis. 2001 Apr;20(4):288-91. doi: 10.1007/pl00011267.
9
In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus.肺炎链球菌、化脓性链球菌和金黄色葡萄球菌对六种喹诺酮类药物的体外耐药性发展情况。
Antimicrob Agents Chemother. 2001 Mar;45(3):938-42. doi: 10.1128/AAC.45.3.938-942.2001.
10
[In vitro bactericidal effect of temafloxacin and tosufloxacin against streptococci].替马沙星和托氟沙星对链球菌的体外杀菌作用
Pathol Biol (Paris). 1991 Dec;39(10):1002-5.

引用本文的文献

1
New species genetic approach to identify strains of mitis group streptococci that are donors of rifampin resistance to Streptococcus pneumoniae.新型物种遗传学方法鉴定米氏链球菌属中对肺炎链球菌具有利福平耐药性的供体菌株。
Antimicrob Agents Chemother. 2011 Jan;55(1):368-72. doi: 10.1128/AAC.00856-10. Epub 2010 Nov 1.
2
Fitness of Streptococcus pneumoniae fluoroquinolone-resistant strains with topoisomerase IV recombinant genes.具有拓扑异构酶IV重组基因的肺炎链球菌氟喹诺酮耐药菌株的适应性
Antimicrob Agents Chemother. 2008 Mar;52(3):822-30. doi: 10.1128/AAC.00731-07. Epub 2007 Dec 26.
3
Emergence of quinolone resistance among viridans group streptococci isolated from the oropharynx of neutropenic peripheral blood stem cell transplant patients receiving quinolone antimicrobial prophylaxis.
在接受喹诺酮类抗菌药物预防治疗的中性粒细胞减少外周血干细胞移植患者的口咽部分离出的草绿色链球菌中出现喹诺酮耐药性。
Eur J Clin Microbiol Infect Dis. 2005 Dec;24(12):832-8. doi: 10.1007/s10096-005-0037-3.
4
Risk factors associated with colonization by pneumococci with reduced susceptibility to fluoroquinolones in adult outpatients.成年门诊患者中与对氟喹诺酮类药物敏感性降低的肺炎球菌定植相关的危险因素。
J Clin Microbiol. 2005 Mar;43(3):1193-7. doi: 10.1128/JCM.43.5.1193-1197.2005.
5
Moxifloxacin: a review of its use in the management of bacterial infections.莫西沙星：其在细菌感染治疗中的应用综述
Drugs. 2004;64(20):2347-77. doi: 10.2165/00003495-200464200-00006.
6
Meropenem prevents levofloxacin-induced resistance in penicillin-resistant pneumococci and acts synergistically with levofloxacin in experimental meningitis.
Eur J Clin Microbiol Infect Dis. 2003 Nov;22(11):656-62. doi: 10.1007/s10096-003-1016-1. Epub 2003 Oct 14.